Conclusion
In summary, it is believed that tumor hemorrhage is likely the result of local disturbances in hemostasis. Such disturbances are caused, at least in part, by the established imbalances in the fibrinolytic factors contained in the brain tumor tissue itself.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Oldberg E: Hemorrhage into gliomas: A review of eight hundred and thirty-two consecutive verified cases of gliomas. Arch Neurol Psychiatry 30: 1061–1073, 1933
Globus JH, Sapirstein M: Massive hemorrhage into brain tumor. JAMA 120: 348–352, 1942
Drake CG, McGee D: Apoplexy associated with brain tumors. Can Med Assoc J 84: 303–305, 1961
Pia HW: The surgical treatment of intracerebral and intraventricular haematomas. Acta Neurochir(Wien) 27: 149–164, 1972
Padt JP, De Reuck J, vander Eecken H: Intracerebral hemorrhage as initial symptom of a brain tumor. Acta Neurol Belg 73: 241–251, 1973
Jellinger K: Pathology and aetiology of ICH. In: Pia HW, Langmaid C, Zierski J (eds) Spontaneous Intracerebral Haematoma: Advances in Diagnosis and Treatment. Berlin, Springer, 1980, pp 13–29
Wakai S, Yamakawa K, Manaka S, Takakura K: Spontaneous intracranial hemorrhage caused by brain tumor. Its incidence and clinical significance. Neurosurgery 10: 437–444, 1982
Scott M: Spontaneous intracerebral hematoma caused by cerebral neoplasms. J Neurosurg 42: 338–342, 1975
Castillo R, Watts C, Pulliam M: Sudden hemorrhage in an acoustic neuroma. Case report. J Neurosurg 42: 338–342, 1975
Lee JP, Wang ADJ: Acoustic neurinoma presenting as intratumoral bleeding. Neurosurgery 24: 764–768, 1989
Fukamachi A, Koizumi H, Nukui H: Postoperative intracerebral hemorrhages: a survey of computed tomographic findings after 1074 intracranial operations. Surg Neurol 23: 575–580, 1985
Kalfas IH, Little JR: Postoperative hemorrhage: a survey of 4992 intracranial procedures. Neurosurgery 23: 343–347, 1988
Scatliff JH, Radcliffe WB, Pittman HH, Park CH: Vascular structure of glioblastomas. AJR 105: 795–805, 1969
Cowen RL, Siqueria EB, George E: Angiographic demonstration of a glioma involving the wall of the anterior cerebral artery: Report of a case. Radiology 97: 577–578, 1970
Hart MN, Byer JA: Rupture of middle cerebral artery branches by invasive astrocytoma. Neurology (NY) 24: 1171–1174, 1975
Morozov VV: The coagulative and anticoagulative blood systems in cerebral tumors of a supratentorial localization. Zh Nevropatol Psikhiatr Korsakova 68: 505–509, 1968
Morozov VV: Blood coagulation properties in patients with supratentorial tumors during pre- and postoperative periods. Vopr Neirokhir 34: 56–60, 1970
Burgman GP, Kachkov IA, Vial'tseva IN, Shcherbakova CG: The state of blood coagulation in patients with glial tumors of the brain. ZH Vopr Neirokhir 3: 34–39, 1979
Scharrer I, Hubner H: Studies of fibrinolysis in patients with metastasizing malignomas and in patients with non-metastasizing cerebral tumors. Verh Dtsch Ges Inn Med 83: 1144–1148, 1977
Oka K, Tsuda H, Kamikaseda K, Nakamura R, Fukui M, Nouzuka Y, Sueishi K: Meningiomas and hemorrhagic diatheis. J Neurosurg 69: 356–360, 1988
Tsuda H, Oka K, Noutsuka Y, Sueishi K: Tissue-type plasminogen activator in patients with intracranial meningiomas. Thromb Haemostas 60: 508–513, 1988
Oka K, Tsuda H, Kohno S, Sueishi K, Tashima T, Fukui M, Tomonaga M: Operation and hemorrhagic diathesis on patients with meningiomas. Brain Tumor Pathol (Tokyo) 7: 89–97, 1990
Sawaya R, Ramo OJ, Glas-Greenwalt P, Wu SZ: Plasma fibrinolytic profile in patients with brain tumors. Thromb Haemostas 65: 15–19, 1991
Bock F, Kraus H, Blumel G, Koos W: Fibrinolytic activity of the cerebral tumors. Neurochirurgie (Paris) 16: 542–547, 1970
Tovi D, Pandolfi M, Astedt B: Local haemostasis in brain tumours. Experientia 31: 977–978, 1975
Koos W, Kraus H, Blumel G, Bock F: The mood of action of proteinases inhibitors (Trasylol) in intracranial hemorrhages. Neurochirurgie (Paris) 16: 548–500, 1970
Sawaya R, Highsmith R: Plasminogen activator activity and molecular weight patterns in human brain tumors. J Neurosurg 68: 73–79, 1988
Soreq H, Miskin R: Plasminogen activator in the rodent brain. Brain Res 216: 361–374, 1981
Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 139–266, 1985
Danø K, Dabelsteen E, Nielsen LS, Kaltoft K, Wilson EL, Zeuthen J: Plasminogen activating enzyme in cultured glioblastoma cells. An immunofluorescence study with monoclonal antibody. J Histochem Cytochem 30: 1165–1170, 1982
Blasi R, Ricco A, Sebatio G: In: Blasi F (eds) Human plasminogen activators. Genes and proteins structure. Human genes and Disease. London, J Wiley & Sons, 1986, pp 377–414
Blasi F: Surface receptors for urokinase plasminogen activator. Fibrinolysis 2: 73–84, 1988
Wilhelm O, Hafter R, Henschen A, Schmitt M, Graeff H: Role of plasmin in the degradation of the stroma-derived fibrin in human ovarian carcinoma. Blood 75: 1673–1678, 1990
Tryggvason K, Hoyhtya M, Salo T: Proteolytic degradation of extracellular matrix in tumor invasion. Biochem Biophys Acta 907: 191–217, 1987
Drake TA, Morrissey JH, Ediginton TS: Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostatis and thrombosis. Am J Pathol 134: 1087–1097, 1989
Fleck RA, Rao LVM, Rapaport SI, Varki N: Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Throm Res 57: 765–781, 1990
Eddleston M, de la Torre JC, Oldstone MBA, Loskutoff DJ, Edgington TS, Mackman N: Astrocytes are the primary source of tissue factor in the murine central nervous system. J Clin Invest 92: 349–358, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oka, K., Tsuda, H., Sakamoto, S. et al. Plasminogen activator and hemorrhage in brain tumors. J Neuro-Oncol 22, 183–187 (1994). https://doi.org/10.1007/BF01052893
Issue Date:
DOI: https://doi.org/10.1007/BF01052893